Results 131 to 140 of about 25,820 (298)

Estimated glomerular filtration rate is a poor predictor of the concentration of middle molecular weight uremic solutes in chronic kidney disease [PDF]

, 2012
Background: Uremic solute concentration increases as Glomerular Filtration Rate (GFR) declines. Weak associations were demonstrated between estimated GFR (eGFR) and the concentrations of several small water-soluble and protein-bound uremic solutes ...
Barreto, Daniela V, Barreto, Fellype C, Eloot, Sunny, Glorieux, Griet, Lemke, Horst D, Lenglet, Aurélie, Liabeuf, Sophie, Massy, Ziad A, Neirynck, Nathalie, Vanholder, Raymond   +9 more
core   +5 more sources

Transient Pseudohypoparathyroidism as a Cause of Late-onset Hypocalcemia in Neonates and Infants

Journal of the Formosan Medical Association, 2008
Transient pseudohypoparathyroidism is a rare cause of late-onset hypocalcemia in neonates and infants. The purpose of this study was to investigate the clinical presentation and natural course of transient pseudohypoparathyroidism in neonates and infants.
Cheng-Ting Lee, Wen-Yu Tsai, Yi-Ching Tung, Yong-Kwei Tsau   +3 more
doaj   +1 more source

Oxygen Transport during Acute Alkalosis and Hyperphosphatemia in Dogs [PDF]

, 1974
Mark O. Farber, F Manfredi, Kenneth F. Atkinson, Thomas C. Passo   +3 more
openalex   +1 more source

A comparison of clinically useful phosphorus binders for patients with chronic kidney failure [PDF]

, 2004
A comparison of clinically useful phosphorus binders for patients with chronic kidney failure. Over the past 30 years it has become apparent that hyperphosphatemia plays a major causative role across the entire spectrum of morbidity associated with ...
Emmett, Michael
core   +1 more source

Phosphate

Journal of Pediatric Critical Care, 2019
Phosphate plays an important role in cell structure and metabolism. Less than 1% of phosphate is in circulating serum and maintained within narrow range by hormones PTH, calcitonin, FGF23, vitamin D.
Kundan Mittal
doaj   +1 more source

Calcium acetate versus calcium carbonate in the control of hyperphosphatemia in hemodialysis patients [PDF]

, 2000
Eufrônio José D Almeida Filho, Elisa de Albuquerque Sampaio da Cruz, Marcos Hoette, Frederico Ruzany, Luana Neves Lopes Keen, Jocemir Ronaldo Lugon   +5 more
openalex   +1 more source

Use of phosphate binders in end-stage renal disease: An experience from a secondary care hospital in United Arab Emirates

Journal of Pharmacy and Bioallied Sciences, 2019
Objective: Hyperphosphatemia in end-stage renal disease (ESRD) is associated with many serious patient-level consequences including cardiovascular events and mortality.
Syed Arman Rabbani, Sathvik B Sridhar, Padma G M Rao, Martin T Kurian, Basset E Essawy   +4 more
doaj   +1 more source

Hyperphosphatemia Modestly Retards Parathyroid Hormone Suppression during Calcitriol-Induced Hypercalcemia in Normal and Azotemic Rats [PDF]

, 2002
Aquiles Jara, Cecilia Chacón, Arnold J. Felsenfeld   +2 more
openalex   +1 more source

Update on tumor lysis syndrome management

Journal of Health Science and Medical Research (JHSMR), 2006
Tumor lysis syndrome (TLS) is an oncologic emergency resulting from rapid cancer cell destruction as a result of spontaneous tumor necrosis or treatment-related cell lysis.
P Angsuwatcharakon, P Sunpaweravong
doaj  

Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan—A Phase 2 Randomized Trial

Kidney International Reports, 2022
Introduction: Simplified, but effective, hyperphosphatemia treatments with novel mechanisms of action, tolerable safety profiles, and low pill burden are needed for patients undergoing hemodialysis.
Masaaki Inaba, Yotaro Une, Kazuaki Ikejiri, Hironori Kanda, Masafumi Fukagawa, Tadao Akizawa   +5 more
doaj